Shuttle Pharmaceuticals Holdings (SHPH) Change in Accured Expenses (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Change in Accured Expenses history runs 6 years deep, the most recent figure standing at $335951.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 322.49% year-over-year to $335951.0; the TTM figure through Mar 2026 stood at $679428.0 (up 946.77% YoY), while the FY2025 annual figure was $422994.0, up 2909.47% from the prior year.
• Change in Accured Expenses was $335951.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$453303.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.1 million in Q3 2024 to a low of -$1.1 million in Q4 2024.
• Historically, Change in Accured Expenses has averaged $32945.2 across 5 years, with a median of $4573.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Change in Accured Expenses tumbled 1150.59% in 2024, then surged 17928.92% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $9592.0 in 2022, then surged by 972.35% to $102860.0 in 2023, then sank by 1150.59% to -$1.1 million in 2024, then jumped by 58.05% to -$453303.0 in 2025, then jumped by 174.11% to $335951.0 in 2026.
• The last three Change in Accured Expenses figures came in at $335951.0 (Q1 2026), -$453303.0 (Q4 2025), and $331198.0 (Q3 2025), per Business Quant data.